| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/23/2009 | CA2712572A1 Reaction device, reaction method and method of synthesizing cdna |
| 07/23/2009 | CA2712151A1 Cellulase variants with reduced inhibition by glucose |
| 07/23/2009 | CA2712057A1 Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compound |
| 07/23/2009 | CA2711962A1 Improved mammalian expression vectors and uses thereof |
| 07/23/2009 | CA2711633A1 Maize plants characterised by quantitative trait loci (qtl) |
| 07/23/2009 | CA2710619A1 Inhibiting angiogenesis using egfl8 antagonists |
| 07/23/2009 | CA2710439A1 Methods for increasing the therapeutic efficacy of immunoglobulin g class 3 (igg3) antibodies |
| 07/23/2009 | CA2708278A1 Compositions and methods for the suppression of target polynucleotides from lepidoptera |
| 07/23/2009 | CA2707361A1 Compositions and methods for the suppression of target polynucleotides |
| 07/22/2009 | EP2081028A1 Use of a polypeptide to detect, prevent or treat a pathological state associated with a degenerative, neurological, autoimmune illness |
| 07/22/2009 | EP2080813A1 Nucleic acid ligands that bind to and inhibit DNA polymerases |
| 07/22/2009 | EP2080809A1 Production of modified glycoproteins having multiple antennary structures |
| 07/22/2009 | EP2080808A1 Method for production of l-amino acid |
| 07/22/2009 | EP2080805A1 Plant expression vectors |
| 07/22/2009 | EP2080804A1 Modified cytokines for use in cancer therapy |
| 07/22/2009 | EP2080803A1 Plastid transformation vectors for expressing proinsulin fused to the cholera toxin B-subunit in plants |
| 07/22/2009 | EP2080802A2 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 07/22/2009 | EP2080801A1 Production of non-ribosomal peptides in Saccharomyces |
| 07/22/2009 | EP2080772A2 Recombinant polypeptides and methods for detecting and/or quantifying autoantibodies against TSH receptor |
| 07/22/2009 | EP2080771A2 New interferon beta-like molecules |
| 07/22/2009 | EP2080768A1 Method for studying virus particle release |
| 07/22/2009 | EP2080767A1 Composition for introduction of nucleic acid |
| 07/22/2009 | EP2080766A1 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 07/22/2009 | EP2080525A1 Remodeling and Glycoconjugation of Peptides |
| 07/22/2009 | EP2080520A1 Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiogenesis |
| 07/22/2009 | EP2080432A1 Sugar and lipid metabolism regulators in plants III |
| 07/22/2009 | EP2080029A2 Means and methods for detecting protein-peptide interactions |
| 07/22/2009 | EP2079842A1 Generation of recombinant dna by sequence-and ligation-independent cloning |
| 07/22/2009 | EP2079841A2 Use of low ph to modify the texture of structured plant protein products |
| 07/22/2009 | EP2079840A1 Immunotox n fusions comprising an antibody fragment and a plant toxin linked by protease cleavable linkers |
| 07/22/2009 | EP2079839A1 Assessment of risk for colorectal cancer |
| 07/22/2009 | EP2079838A1 Nucleic acid separation and purification method based on reversible charge interactions |
| 07/22/2009 | EP2079837A1 Method for obtaining variants of lactic bacteria useful in the production of k2 vitamin and applications for the preparation of food products |
| 07/22/2009 | EP2079835A2 Compositions and methods of using chondroitinase abci mutants |
| 07/22/2009 | EP2079761A2 Prevention of aggregation of immunoglobulin light or heavy chains |
| 07/22/2009 | EP2079755A1 Process for generation of protein and uses thereof |
| 07/22/2009 | EP2079526A1 Compositions and uses thereof in the treatment of wounds |
| 07/22/2009 | EP2006377A9 Novel tumor antigen peptides |
| 07/22/2009 | EP2006375A9 Panel cell used for granulocyte antibody detection |
| 07/22/2009 | EP2006293A9 2'-hydroxyl-modified ribonucleoside derivative |
| 07/22/2009 | EP1904622A4 Constitutive promoters from poplar and uses thereof |
| 07/22/2009 | EP1874927A4 Improved cellulases |
| 07/22/2009 | EP1863846B1 Human synthetic single-chain antibodies directed against the common epitope of mutant p53 and their uses |
| 07/22/2009 | EP1651751A4 Engineered proteases for affinity purification and processing of fusion proteins |
| 07/22/2009 | EP1605040B1 Monocyte-origin multipotent cell momc |
| 07/22/2009 | EP1592704B1 Leukocyte stimulating peptides |
| 07/22/2009 | EP1511767B1 A purified polypeptide, isolated nucleic acids encoding said polypeptide, vectors and use thereof |
| 07/22/2009 | EP1509623B1 Amplification of ribonucleic acids |
| 07/22/2009 | EP1471937B1 A continuous cell line for the production of vaccines |
| 07/22/2009 | EP1443053B1 Analgesic antitumor peptide from scorpion and method of producing it |
| 07/22/2009 | EP1432791B1 Alphavirus replicon vector systems |
| 07/22/2009 | EP1395669B1 Matrix attachment regions and methods for use thereof |
| 07/22/2009 | EP1395293B1 Lentiviral vectors encoding clotting factors for gene therapy |
| 07/22/2009 | EP1357938B1 Hyperblebbing bacterial strains and use thereof for production of vaccines |
| 07/22/2009 | EP1329523B1 Method of detecting norwalk-like virus (gii) |
| 07/22/2009 | EP1327679B1 Method of synthesizing polynucleotide |
| 07/22/2009 | EP1292697B1 Method for preparing a physiologically active il-18 polypeptide |
| 07/22/2009 | EP1288661B1 Method for examining wt1-related disease |
| 07/22/2009 | EP1280900B1 Dendritic cell co-stimulatory molecules |
| 07/22/2009 | EP1255563B1 Composition of antigen and glycolipid adjuvant sublingual administration |
| 07/22/2009 | EP1246921B1 Increased lysine production by gene amplification using coryneform bacteria |
| 07/22/2009 | EP1220922B1 Method of identifying a compound with efficacy in the treatment of chronic inflammatory diseases |
| 07/22/2009 | EP1133517B1 INTRANUCLEAR TARGETED DELIVERY OF COMPOUNDS BY 70 kD HEAT SHOCK PROTEIN |
| 07/22/2009 | EP1093381B2 Antigenic peptides derived from telomerase |
| 07/22/2009 | EP1075283B1 A process of delivering a polynucleotide to a cell via the vascular system |
| 07/22/2009 | EP0873135B1 Peanut allergens and methods |
| 07/22/2009 | CN101490267A Artificial plant minichromosomes |
| 07/22/2009 | CN101490266A Use of non-agrobacterium bacterial species for plant transformation |
| 07/22/2009 | CN101490265A Antifungal polypeptides |
| 07/22/2009 | CN101490264A Methods and compositions for obtaining marker-free transgenic plants |
| 07/22/2009 | CN101490263A Production of pravastatin |
| 07/22/2009 | CN101490262A A method for achieving improved polypeptide expression |
| 07/22/2009 | CN101490261A KEX2 cleavage regions of recombinant fusion proteins |
| 07/22/2009 | CN101490260A Improved production of sphingoid bases using genetically engineered microbial strains |
| 07/22/2009 | CN101490259A Genetic markers for high oleic acid content in plants |
| 07/22/2009 | CN101490258A A method for stimulating angiogenesis using DKK2 and composition comprising the same |
| 07/22/2009 | CN101490257A Multimer for immunostimulation |
| 07/22/2009 | CN101490256A Method of determining size of fatty acid content in intramuscular fat of cattle based on genotype of fatty acid synthase and method of determining eating quality of beef based on the result |
| 07/22/2009 | CN101490255A Primer set for amplification of NAT2 gene, reagent for amplification of NAT2 gene comprising the same, and use of the same |
| 07/22/2009 | CN101490253A Means for inhibiting the expression of protein kinase 3 |
| 07/22/2009 | CN101489566A Rnai modulation of aha and therapeutic uses thereof |
| 07/22/2009 | CN101489383A Delivery method |
| 07/22/2009 | CN101487021A Use of miR397 in drought resistance plant cultivation |
| 07/22/2009 | CN101487020A Preparation and use of recombinant gold needle mushroom immunomodulatory protein |
| 07/22/2009 | CN101487019A Candida utilis expression vector and construction method thereof |
| 07/22/2009 | CN101487018A Construction method and use of Mycobacterium tuberculosis gene expression library |
| 07/22/2009 | CN101487017A Hog cholera indirect hemagglutination detection kit and preparation |
| 07/22/2009 | CN101487016A Avian influenza vaccine and preparation thereof |
| 07/22/2009 | CN101487015A Method for producing DSPA alpha 1 by yeast expression system |
| 07/22/2009 | CN101487014A Preparation and use of wild silkworm 1 acetylcholine esterase active protein |
| 07/22/2009 | CN101487013A Detection of PTP1B gene mutation and use thereof in cancer diagnosis |
| 07/22/2009 | CN101487012A Genetic sequences encoding flavonoid pathway enzymes and uses therefor |
| 07/22/2009 | CN101487011A Molecular design for simulating IBDV multi-epitope gene and use thereof |
| 07/22/2009 | CN101487010A Method for preparing vaccine for anti-HPV 18 infection by pichia yeast expression system |
| 07/22/2009 | CN101487009A Method for preparing vaccine for anti-HPV 16 infection by pichia yeast expression system |
| 07/22/2009 | CN101487008A Bacillus licheniformis integration expression box and use thereof |
| 07/22/2009 | CN101487007A Operon for synthesizing Pantoea agglomerans beta-carotene, expression vector and use thereof |
| 07/22/2009 | CN101487006A Cloning and function of Chinese cabbage LRR disease-resistant protein gene BcLRR |
| 07/22/2009 | CN101487005A Gene of human vascular endothelial growth factor monoclonal antibody and use thereof |
| 07/22/2009 | CN101486761A Human coagulation factor VII variants |